1. Home
  2. SEER vs QMLS Comparison

SEER vs QMLS Comparison

Compare SEER & QMLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

N/A

Current Price

$1.74

Market Cap

113.0M

Sector

Health Care

ML Signal

N/A

Logo QumulusAI Inc. Common Stock

QMLS

QumulusAI Inc. Common Stock

N/A

Current Price

$3.19

Market Cap

127.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SEER
QMLS
Founded
2017
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
113.0M
127.1M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
SEER
QMLS
Price
$1.74
$3.19
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$4.00
★ $14.33
AVG Volume (30 Days)
167.0K
★ 279.5K
Earning Date
11-10-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 9.40
N/A
EPS
N/A
★ N/A
Revenue
★ $16,578,000.00
N/A
Revenue This Year
N/A
$385.47
Revenue Next Year
$20.50
$413.89
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 16.99
N/A
52 Week Low
$1.55
$3.10
52 Week High
$2.38
$14.82

Technical Indicators

Market Signals
Indicator
SEER
QMLS
Relative Strength Index (RSI) 32.98 33.48
Support Level $1.70 $3.10
Resistance Level $1.81 $7.38
Average True Range (ATR) 0.10 0.34
MACD -0.04 0.04
Stochastic Oscillator 25.00 13.94

Price Performance

Historical Comparison
SEER
QMLS

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About QMLS QumulusAI Inc. Common Stock

QumulusAI Inc is a cloud infrastructure company engaged in the rapid deployment of graphics processing unit (GPU)-powered solutions for artificial intelligence (AI) applications, serving a critical market that is often overlooked by large-scale cloud providers (hyperscalers), which operate massive, standardized computing infrastructures serving the immense enterprises. The platform delivers flexible, competitively priced, and customizable solutions for underserved small- and mid-market customers, including machine learning teams, AI infrastructure startups, and research institutions, and also supports the scale and complexity requirements of large enterprises. Its products are B300 SXM6, B200 SXM, RTX Pro 6000, H200 SXM, and Others. Its solutions are Enterprise, Research, and AI Startups.

Share on Social Networks: